APLS Research and Charts

APLS - Apellis Pharmaceuticals Inc (Healthcare: Biotechnology)

Projected Earnings Date: 2025-08-06 (Delayed quote data 2025-07-11)

Last 19.44	Change ⇓ -0.09 (-0.46%)	Volume 1,549,984
	Open 19.23	High 19.54	Low 18.98

8EMA (Daily) 18.57	40EMA (Daily) 18.59	50EMA (Daily) 18.89	STO (Daily) 60.177	MACD Hist (Daily) 0.366
8EMA (Weekly) 18.540	40EMA (Weekly) 25.10	50EMA (Weekly) 27.29	STO (Weekly) 31.784	MACD Hist (Weekly) 1.021


Company Profile
Apellis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It focused on the development of novel therapeutic compounds to treat disease through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3 the central protein in the complement cascade.

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.